Akebia Therapeutics Q3'26 Earnings Preview: EPS Estimate at $(0.04)
Akebia Therapeutics is scheduled to report Q3'26 results on October 29; the release time is unspecified. EPS is estimated at $(0.04).
AKBA (Akebia Therapeutics, Inc.) is set to announce its Q3'26 results on October 29, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 46.94 million USD with EPS (earnings per share) anticipated at (0.04) USD. Learn more detail…